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Blood cells participate in vital physiological processes, and their numbers are tightly regulated so that homeostasis is maintained. Disrup-
tion of key regulatory mechanisms underlies many blood-related Mendelian diseases but also contributes to more common disorders,
including atherosclerosis. We searched for quantitative trait loci (QTL) for hematology traits through a whole-genome association study,
because these could provide new insights into both hemopoeitic and disease mechanisms. We tested 1.8 million variants for association
with 13 hematology traits measured in 6015 individuals from the Australian and Dutch populations. These traits included hemoglobin
composition, platelet counts, and red blood cell and white blood cell indices. We identiﬁed three regions of strong association that, to
our knowledge, have not been previously reported in the literature. The ﬁrst was located in an intergenic region of chromosome 9q31
near LPAR1, explaining 1.5% of the variation in monocyte counts (best SNP rs7023923, p ¼ 8.9 3 1014). The second locus was located
on chromosome 6p21 and associated with mean cell erythrocyte volume (rs12661667, p ¼ 1.2 3 109, 0.7% variance explained) in
a region that spanned ﬁve genes, including CCND3, a member of the D-cyclin gene family that is involved in hematopoietic stem
cell expansion. The third region was also associated with erythrocyte volume and was located in an intergenic region on chromosome
6q24 (rs592423, p ¼ 5.3 3 109, 0.6% variance explained). All three loci replicated in an independent panel of 1543 individuals
(p values ¼ 0.001, 9.9 3 105, and 7 3 105, respectively). The identiﬁcation of these QTL provides new opportunities for furthering
our understanding of the mechanisms regulating hemopoietic cell fate.Blood cells play an integral role in vital physiological
processes, from gas transport to blood clotting and various
aspects of immunity. Their production, sequestration, and
apoptosis is under complex regulatory control, which can
be compromised in rare clinical conditions such as hemo-
philia (MIM 306900) but also, to some extent, in more
common disorders, including asthma (MIM 600907)1
and atherosclerosis (MIM 209010).2 Therefore, important
insights into the etiology of these conditions can be gained
from a detailed understanding of the molecular mecha-
nisms regulating blood cell numbers. Given the large vari-
ation in blood cell numbers between individuals and their
documented high heritability,3 we sought to map new
quantitative trait loci (QTL) for a variety of hematology
traits through a whole-genome association study and
reasoned that these could provide new insights into the
mechanisms regulating hemopoietic cell fate.
Thirteen hematology traits were measured in the periph-
eral blood of up to 6015 individuals from the Australian
and Dutch general populations, ascertained and clinically
tested as described in detail elsewhere.3–6 The traits
measured included total blood hemoglobin (Hb), red blood
cell count (RBC), mean cell erythrocyte volume (MCV),
platelet count (PLT), and white blood cell count (WBC).The AmericaFrom these values, the derived traits hematocrit (HT),
mean cell hemoglobin (MCH), and mean cell hemoglobin
concentration (MCHC) were calculated through the appro-
priate formulae. A ﬁve-part differential provided estimates
for neutrophil (NEUT), monocyte (MONO), eosinophil
(EOS), basophil (BASO), and lymphocyte (LYMPH) counts
(Table S1, available online). For each trait, outlier observa-
tions (six standard deviations [SD] above the mean) were
excluded from analysis and an inverse normal transforma-
tion was applied so that normality was ensured. For the
Australian cohort, phenotypes were measured in some
individuals at three time points (ages 12, 14, and 16) and
for these the average across all available data was
computed. Trait heritabilities ranged from 35% to 94%,
with low to moderate cross-trait phenotypic correlations
(Table S2).
Genotyping was performed with Illumina (Australian
cohort) and Perlegen (Dutch cohort) chips, with 529,721
and 435,291 single-nucleotide polymorphisms (SNP),
respectively, passing quality control (QC) (Table S3). To
facilitate the combinedanalysis of bothcohorts,we inferred
unmeasured HapMap SNPs in each panel separately by
using the MACH program (see Web Resources). In brief,
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Table 1. Loci Associated with Variation in Monocyte Count and Mean Erythrocyte Cell Volume
Locus Trait SNP, Allelea Panel Na
Allele





9q31 Monocytes rs7023923, C GWAS 4225 0.50 0.17 0.02 1.5 8.9 3 1014 0.691
Replication 1517 0.48 0.12 0.04 0.8 0.001 0.104
6p21 MCV rs12661667, C GWAS 5946 0.73 0.13 0.02 0.7 1.2 3 109 0.078
Replication 1542 0.75 0.17 0.05 1.2 9.9 3 105 0.245
6q24 MCV rs592423, C GWAS 5938 0.53 0.11 0.02 0.6 5.3 3 109 0.305
Replication 1405 0.56 0.15 0.04 0.9 7.2 3 105 0.361
Abbreviations are as follows: MCV, mean cell volume; N, sample size; SE, standard error.
a Sample size corresponds to the number of phenotyped and genotyped individuals. For the Australian cohort, genotype data from 1457 parents who were not
phenotyped were also included in the analysis.
b Effect corresponds to standard-deviation units for the transformed phenotype.
c h2 represents the proportion of phenotypic variance explained by the SNP.
d Results for the test of heterogeneity of effect size between the two samples that form the GWAS panel (Australian [n ¼ 2538] and Dutch [n ¼ 3477] cohorts) or
between the two samples that form the replication panel (Busselton [n ¼ 1294] and GenomeEUtwin [n ¼ 249] cohorts). A significant p value indicates significant
evidence for heterogeneity.individuals to the phased haplotype data from the CEU
HapMap samples (phase IþII, release22, build 36) to
generate recombination and error maps. We then used
these to impute unmeasured SNPs for each group by
using the same reference panel. After imputation, data for
2.5 million Hapmap SNPs were available for the Australian
and Dutch cohorts. Of these, in each cohort we dropped
SNPs with an imputation score< 0.3 (indicating low impu-
tation conﬁdence; ~2% of SNPs), a minor allele frequency
(MAF) < 0.01, or a Hardy-Weinberg (HW) equilibrium test
p < 106 (3%). Next, we merged data from both cohorts
and further excluded SNPs if they were imputed with high
conﬁdence in only one cohort (3%), failed the MAF or
HW thresholds in the overall sample (1%), or had signiﬁ-
cant allele frequency differences between the two cohorts
(p < 0.001, 19%). After these exclusions, there remained
1,872,254 SNPs available for analysis. Simulations showed
that this data set was well powered for the detection of
a QTL that explained ~0.8% of the phenotypic variance
(Figure S1). This study was performed with the approval of
the appropriate ethics committee and with informed
written consent from all participants.
Individual SNPs were tested for association under an
additive model with the use of the family-based SCORE
test implemented in Merlin7 after adjustment for the
signiﬁcant effects of age, sex, and time of day of blood
collection (including a square component). Similar results
were obtained for our top regions of association with the
more computationally intensive variance-components
likelihood-ratio test, which accounts for identity-by-
descent sharing when modeling the correlation between
relatives (not shown). The genomic inﬂation factor ranged
between 1.00 and 1.02 (Figure S2), indicating that poten-
tial technical or population-stratiﬁcation artifacts had a
negligible impact on the results.
Genome-wide association study (GWAS) results for the
combined analysis of the Australian and Dutch cohorts
are shown in Figure S3 and are available for download746 The American Journal of Human Genetics 85, 745–749, Novem(see Web Resources). Six loci exceeded our signiﬁcance
threshold of p ¼ 5.5 3 109, which was adjusted to
account for the effective number of independent traits
tested (n ¼ 9, p ¼ 5 3 108 / 9 ¼ 5.5 3 109).
Of the six loci reaching experiment-wide signiﬁcance,
three have not previously been reported as associating
with hematology traits (Table 1). The ﬁrst of these was
located 124 kb upstream of the lysophosphatidic acid
receptor 1 gene (LPAR1 [MIM 602282]) on chromosome
9q31 (Figure 1A), with multiple SNPs associated with
monocyte counts (best SNP: rs7023923; p ¼ 8.9 3 1014,
explaining 1.5% of the trait variance). This locus did not
inﬂuence the variation of other blood cell levels (not
shown).
The second locus was located on chromosome 6p21
and associated with mean cell erythrocyte volume
(rs12661667; p ¼ 1.2 3 109, 0.7% variance explained),
a region that spanned 133 kb and included ﬁve genes
(Figure 1B), the most notable of these a member of the
D-cyclin gene family (CCND3 [MIM 123834]), which is
thought to be critical for expansion of hematopoietic
stem cells.8 The third region was also associated with eryth-
rocyte volume and was located in an intergenic region
on chromosome 6q24 (rs592423; p ¼ 5.3 3 109, 0.6%
variance explained [Figure 1C]). The 6p21 and 6q24
loci also accounted for a signiﬁcant proportion of the vari-
ation in mean cell hemoglobin levels (0.5% for both; p ¼
1.3 3 105 and p ¼ 4.0 3 105, respectively). There was
no evidence for signiﬁcant heterogeneity of effects
between the Australian and Dutch cohorts for these three
regions (Table 1).
We ﬁrst sought to conﬁrm the three associations that
had not been previously published and that reached
genome-wide signiﬁcance in our discovery sample in an
independent replication panel (n ¼ 1543), also ascertained
from the general population. Two studies contributed data
for replication: the longitudinal Busselton Health Study9,10
and the GenomEUtwin Study.11 The Busselton Healthber 13, 2009
Figure 1. Main Association Results
(A–C) Regional association plots for three previously unpublished loci associated with peripheral-blood monocyte counts (A) and mean
cell erythrocyte volume (MCV; B and C). The most-associated SNP for each region is shown in blue, and the color of the remaining
markers reﬂects the linkage disequilibrium (r2) with the top SNP in each panel (increasing red hue associated with increasing r2). The
recombination rate (second y axis) is plotted in light blue and is based on the CEU HapMap population. Exons for each gene are repre-
sented by vertical bars, based on all isoforms available from the March 2006 UCSC Genome Browser assembly.
(D) Mean MCV volume (main y axis) as a function of the number of high-MCV alleles at ﬁve conﬁrmed MCV loci: 6p21 (rs12661667),
6q24 (rs592423), HBS1L/MYB (rs11154792), TMPRSS6 (rs4820268), and HFE (rs1408272). The gray curve represents the population
frequency (second y axis) of the ten observed cumulative allele categories. Vertical bars correspond to the 95% conﬁdence interval
around the mean.Study consists of cross-sectional,whole-population health
surveys conducted at intervals of 3 yrs in adults residing
in Busselton, Western Australia. For this study, data were
available for 1294 adults (57% females: mean age 53, range
17–91) tested in 1994 and 1995 and genotyped on the
Illumina Human 610-Quad BeadChip. The GenomEUtwin
Study consists of an unselected population-based cohort of
twins genotyped with the Illumina HumanHap300-Duo
BeadChip; phenotypes were available for 249 unrelated
monozygotic females (mean age 33, range 17–69). SNPs
that were not directly genotyped in either study were
imputed with high conﬁdence (imputation score > 0.95)
with the MACH (Busselton, rs592423 and rs7023923) or
PLINK (GenomEUtwin, all three variants) program.
The three loci replicated convincingly (p ¼ 0.001 for
monocytes and rs7023923, p ¼ 9.9 3 105 for MCV and
rs12661667, p ¼ 7.2 3 105 for MCV and rs592423),
with the same direction of effect observed in the replica-
tion and GWAS samples (Table 1). These results thus
conﬁrm that genetic variants in these three regions signif-The Americaicantly inﬂuence variation in monocyte counts (9q31) and
erythrocyte volume (6p21 and 6q24). Given the extent of
linkage disequilibrium (LD) and/or the lack of obvious
candidate genes for all three, additional studies will be
required for identiﬁcation of the underlying causal vari-
ants and associated genes. The degree of sequence conser-
vation across mammals suggests that for 9q31, and to
some extent also for 6q24, new exonic or regulatory
regions may be located near the association signal (Figures
1A and 1C).
In addition to these three regions, an additional three
loci that have previously been reported to associate with
hematology traits were identiﬁed with genome-wide sig-
niﬁcance: namely, the HBS1L (MIM 612450)/MYB (MIM
189990) locus,12,13 TMPRSS6 (MIM 609862), and HFE
(MIM 235200).14 Our results for these loci are consistent
with previous ﬁndings (Table S4).
Regions with less-stringent evidence for association,
which we did not attempt to replicate, are listed in Table
S5. Most notable were the associations between hematocritn Journal of Human Genetics 85, 745–749, November 13, 2009 747
and the hexokinase 1 gene (HK1; rs10159477, p ¼ 5.8 3
109), consistent with recent reports;15,16 between neutro-
phil count and the colony-stimulating factor 3 gene (CSF3
[MIM 138970]; rs2227322, p ¼ 9.2 3 107), which stimu-
lates the proliferation and differentiation of granulocyte
progenitor cells;17 and between lymphocyte counts and
the major histocompatibility complex (MHC) locus
(rs3099844, p ¼ 4.7 3 108).
For most traits tested, the combined effect of all identi-
ﬁed QTL to date explains only a small proportion of
the total phenotypic variance. For example, for MCV,
which we estimated to be > 80% heritable (Table S2), the
ﬁve loci that now have conﬁrmed effects for this trait
explained only ~6% of the between-individual variation
in our replication panel, with largely additive effects
within and across loci (Figure 1D). We addressed three
potential factors that could partly explain this discrepancy.
First, we tested whether the remaining unexplained
genetic variance could to some degree be attributed to
heterogeneous effects between populations. We performed
a genome-wide comparison of genetic effects between the
Australian and Dutch cohorts but found that these were
largely comparable (Figure S4).
We also investigated the possibility that multiple inde-
pendent variants with weak effects may exist within a
gene, which our main single-locus analysis would have
been underpowered to detect. We applied a gene-based
approach implemented in PLINK18 to test the overall
evidence for association with 17,062 genes, while account-
ing for the size, number of SNPs, and LD structure for each
gene, but we found no additional loci associated with any
of the traits tested (Table S6).
Finally, we used a multivariate approach19 to search for
loci with weak but potentially pleiotropic effects on
multiple traits that could also have been missed by the
main analysis. We identiﬁed 12 regions that were not de-
tected (p < 105) in the univariate analysis, but these did
not have experiment-wide signiﬁcance (Table S7). Of
note was the association of a nonsynonymous SNP in
the transcription factor 19 gene (TCF19 [MIM 600912];
rs7750641) with lymphocyte count, mean cell hemo-
globin, white blood cell count, hematocrit count, and
eosinophil count (p ¼ 2.3 3 107). Thus, consistent with
recent results for most complex traits and diseases,20 we
conclude that the genetic variants that remain to be iden-
tiﬁed for the hematology traits that we tested are not well
tagged by the current SNP sets and/or have effect sizes that
require larger cohorts to be identiﬁed.
In summary, our analyses identiﬁed a QTL with speciﬁc
regulatory effects on peripheral-blood monocyte numbers
and two loci that inﬂuence erythrocyte volume. Mono-
cytes represent 10% of all leukocytes and develop from
the common myeloid progenitor in the bone marrow
through several commitment steps regulated by growth
and transcription factors.21 Once they emigrate from the
bone marrow to the peripheral blood in response to proin-
ﬂammatory cytokines, monocytes assume their innate748 The American Journal of Human Genetics 85, 745–749, Novemimmune functions, including the removal of apoptotic
cells and toxic compounds.22 Through these, they also play
a key role in healing after myocardial infarction23 and
contribute to the development of inﬂammatory diseases,
including atherosclerosis.2 The currently accepted model
of monocyte development is far from complete,21 so the
identiﬁcation of a conﬁrmed genetic variant for monocyte
numbers in the gene-poor 9q31 region provides new
opportunities for furthering our understanding of mono-
cyte biology and potentially new avenues for the control
of inﬂammatory diseases.
The two variants identiﬁed for erythrocyte volume bring
the total number of conﬁrmed genetic loci for this trait up
to ﬁve (HBS1L/MYB, TMPRSS6, HFE, 6p21, and 6q24). The
size of red blood cells determines not only oxygen carrying
capacity but also diffusibility and ﬂexibility of movement
through capillaries. It is therefore under tight control,
with increased size associated with increased mortality
risk, namely due to cardiovascular disease and lower respi-
ratory tract disease.24 It is therefore paramount to further
characterize the molecular mechanisms underlying the
genetic associations reported in our study, as well as to
investigate the extent to which the ﬁve known QTL
interact with known environmental determinants of cell
size, including iron, folate, vitamin B12, and alcohol.
Supplemental Data
SD six ﬁgures and seven tables and can be found with this article
online at http://www.cell.com/AJHG.
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